Your browser doesn't support javascript.
loading
Reversible widespread brain 18F-FDG PET hypometabolism in chronic fatigue syndrome treated by hyperbaric oxygen therapy.
Mairal, E; Barberon, B; Laine, N; Coulange, M; Guedj, Eric.
Affiliation
  • Mairal E; Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU Nancy, Université de Lorraine, 54000, Nancy, France.
  • Barberon B; APHM, INSERM 1263 - INRA 1260, TEAM V: Adenosinergic System and Cardiovascular Disease, Sainte-Marguerite Hospital, Marseille, Pôle RUSH, Hyperbaric Medicine Centre, Aix Marseille University, Marseille, France.
  • Laine N; APHM, INSERM 1263 - INRA 1260, TEAM V: Adenosinergic System and Cardiovascular Disease, Sainte-Marguerite Hospital, Marseille, Pôle RUSH, Hyperbaric Medicine Centre, Aix Marseille University, Marseille, France.
  • Coulange M; APHM, INSERM 1263 - INRA 1260, TEAM V: Adenosinergic System and Cardiovascular Disease, Sainte-Marguerite Hospital, Marseille, Pôle RUSH, Hyperbaric Medicine Centre, Aix Marseille University, Marseille, France.
  • Guedj E; Aix Marseille Univ, APHM, CNRS, Centrale Marseille, Institut Fresnel, Timone Hospital, CERIMED, Nuclear Medicine Department, Marseille, France. eric.guedj@ap-hm.fr.
Eur J Nucl Med Mol Imaging ; 48(5): 1680-1681, 2021 05.
Article in En | MEDLINE | ID: mdl-33420913
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Fatigue Syndrome, Chronic / Hyperbaric Oxygenation Limits: Humans Language: En Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Fatigue Syndrome, Chronic / Hyperbaric Oxygenation Limits: Humans Language: En Year: 2021 Type: Article